Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 30 n° 318

Almirall launches AlmirallShare, an open innovation platform, to find innovative solutions in skin health

Posted by fidest press agency su giovedì, 21 settembre 2017

almirallAlmirall, S.A. (ALM) has launched AlmirallShare, an open innovation platform designed to facilitate the establishment of collaborations in dermatological research and find innovative solutions in skin health. By putting together the Science and creativity of experts around the world and Almirall’s own expertise, the AlmirallShare initiative will accelerate the generation of new treatments for skin conditions.Almirall focuses its R&D on dermatology and aesthetics, and is continually growing as a specialist company, in order to cover specialists’ and patients’ unmet needs. In the words of Dr. Bhushan Hardas, Executive Vice President R&D, Chief Scientific Officer: “Our R&D strategy is based on three important aspects: Science, innovation, and partnerships. We are convinced that there are plenty of breakthrough ideas and innovation outside our walls. With this in mind, we have created AlmirallShare, our open innovation platform, to help us identify and progress innovative solutions for skin health”. Scientists at Universities, public or private research institutions, hospitals, and biotechnology companies are invited to participate and address the dermatological challenges posted in After the submissions of their proposals, the Almirall team will review them and suggest the best way for the selected proposals to progress.AlmirallShare’s first call is focused on increasing the understanding of skin pathology in diseases such as psoriasis, atopic dermatitis, acne and rosacea. Almirall aims to reach researchers who share this objective in order to establish close working relationships with them and bring together major breakthroughs in this field.The platform also hosts additional collaboration opportunities. The scope of AlmirallShare will be expanded in the future with new calls for collaboration as well as addressing additional dermatological conditions.
Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying Science to provide medical solutions to patients & future generations. Our efforts are focused on fighting against skin health diseases and helping people feel and look their best. We support healthcare professionals in its continuous improvement, bringing our innovative solutions where they are needed. The company, founded in 1943 and with headquarters in Barcelona, is listed on the Spanish Stock Exchange (ticker: ALM). Almirall has become a key element of value creation to society according to its commitment with its major shareholders and its decision to help others, to understand their challenges and to use Science to provide them with solutions for real life. Total revenue in 2016 was 859.3 million euros and more than 2,000 employees are devoted to Science.


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:


Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google+ photo

Stai commentando usando il tuo account Google+. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: